« Diabetes update - Icahn Groups Increase Stake in ImClone and Amylin Shares Jump on End
Heart disease symptoms - Office hours best time to have a heart attack »

Diabetes update - Entelos Announces Research Collaboration 

Entelos, Inc. (LSE: ENTL) today announced acollaboration with Novartis Pharma AG (NYSE: NVS) to conduct research inmultiple disease areas. Under terms of the agreement, Novartis will provideR&D funding and Entelos will conduct biosimulation research using itsPhysioLab platforms that predict the effects of drugs using ‘virtualpatients’. This unique approach will be used by Novartis to support Diabetes Supply

A U.S. company’s ground-breaking technique for growing human stem cells without destroying an embryo has triggered hope the procedure may resolve the ethical and legal dilemmas that have severely limited stem-cell research in this country. Diabetes Supply

Food and mood are contributing factors to stress levels according to Jennifer Allen, nutrition instructor at the Massage Therapy Training Institute in Kansas City, MO. (PRWEB Aug 21, 2006) Diabetes Supply

The road to many an inflammatory disease is guarded by a cytokine messenger protein called interleukin-27, according to researchers from the University of Pennsylvania School of Veterinary Medicine. The Penn researchers found that IL-27 inhibits the immune system cells that are responsible for an array of inflammatory-related diseases, including encephalitis, arthritis, Crohn’s disease, lupus and Diabetes Supply

A Bay Area company’s ground-breaking technique for growing human stem cells without destroying an embryo has triggered hope that the procedure may resolve the ethical and legal dilemmas that have severely limited stem-cell research in this country. Diabetes Supply

This entry was posted on Sunday, August 27th, 2006 at 3:00 am and is filed under Heart Disease. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

  • Related Articles